Timing of first measles vaccine dose linked to effectiveness

An investigation has found that children who received their first dose of the measles vaccine later in life were less likely to become ill during an outbreak. The study showed that kids who received their first dose aged 12 to 13 months had a 6-times-greater risk of contracting measles than those who were given the jab aged 15 months and older. The news comes days after a separate study found delaying the measles vaccine raises the risk of seizures. Abstract

Suggested Articles

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

GSK's Shingrix has nabbed a huge chunk of the U.S. shingles-shot market, just five months after it was approved by the FDA.